NEPHROPLUS vs RELIANCE
Head-to-head DCF comparison · NEPHROCARE HEALTH SERV L vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
NEPHROPLUS
NEPHROCARE HEALTH SERV L
General/Diversified
₹729
Above Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,263
Near Fair Value| Metric | NEPHROPLUS | RELIANCE |
|---|---|---|
| Verdict | Above Fair Value | Near Fair Value |
| YieldIQ Score | 40/100 | 67/100 |
| Fair Value | ₹283 | ₹1,500 |
| Current Price | ₹729 | ₹1,263 |
| Discount to FV | -61.2% | +18.7% |
| Moat | Moderate | Moderate |
| Piotroski F-Score | 7/9 | 4/9 |
| ROE | 9.0% | 8.9% |
| Debt / Equity | 0.07 | 0.37 |
| EV / EBITDA | 24.9× | 9.8× |
| Market Cap | ₹7,315 Cr | ₹17.09 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.